2011
DOI: 10.1097/mcp.0b013e3283463dac
|View full text |Cite
|
Sign up to set email alerts
|

The use of tunneled pleural catheters in the treatment of pleural effusions

Abstract: TPCs are an effective management strategy for symptomatic, recurrent, malignant pleural effusions. Their use as a first-line treatment is feasible and TPCs are particularly preferred for patients with trapped lung or those who are not considered good candidates for chemical pleurodesis because of short life-expectancy. There currently lacks sufficient evidence to recommend the use of TPCs in nonmalignant pleural diseases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(15 citation statements)
references
References 43 publications
0
14
0
1
Order By: Relevance
“…Adverse effects events associated with the indwelling catheter include pleural infection (2.8%) (which can be managed with intravenous antibiotics, leaving the catheter in place), catheter blockage (which can be managed with the instillation of a fibrinolytic into the catheter or replacement of the catheter), and chest pain with the removal of fluid (which can be minimized by draining the fluid more slowly). 44 The primary alternative to insertion of an indwelling pleural catheter is to inject an irritant into the pleural space, which can create an intense inflammatory response, leading to fusion of the visceral and parietal pleural. 1 Many different agents have been used as pleurodesing agents, but doxycycline 500 mg is the agent I recommend.…”
Section: Malignant Pleural Effusionmentioning
confidence: 99%
“…Adverse effects events associated with the indwelling catheter include pleural infection (2.8%) (which can be managed with intravenous antibiotics, leaving the catheter in place), catheter blockage (which can be managed with the instillation of a fibrinolytic into the catheter or replacement of the catheter), and chest pain with the removal of fluid (which can be minimized by draining the fluid more slowly). 44 The primary alternative to insertion of an indwelling pleural catheter is to inject an irritant into the pleural space, which can create an intense inflammatory response, leading to fusion of the visceral and parietal pleural. 1 Many different agents have been used as pleurodesing agents, but doxycycline 500 mg is the agent I recommend.…”
Section: Malignant Pleural Effusionmentioning
confidence: 99%
“…Spontaneous pleurodesis can develop in 40–70% of patients with IPC in situ, which permits catheter removal 5. On other occasions, the IPC may be removed due to cessation of drainage or development of serious complications such as empyema or severe pain.…”
Section: Introductionmentioning
confidence: 99%
“…It is increasingly realised that nonexpandable (or 'trapped') lungs are common in MPEs. 5 A recent study using pleural ultrasound as a screening tool found 50-60% of MPE patients had nonexpandable lungs and poor performance not suitable for talc pleurodesis. 6 IPC, however, can be used for all MPE patients whether the lung is expandable or trapped.…”
Section: Introductionmentioning
confidence: 99%
“…It can be inserted on an outpatient basis as a day care procedure and further care is provided at home by trained healthcare professionals or by family members. However, there is a burden of on-going care such as wound dressing changes and drainages [12]. Nonetheless, according to the TIME2 trial this does not affect the quality of life in these patients [7].…”
Section: Discussionmentioning
confidence: 99%